Palliative Care--an Essential Component of Cancer Control

Overview

Journal CMAJ

Date 1998 Jul 24

PMID 9676548

Authors

N Macdonald

Affiliations

Soon will be listed here.

Abstract

Unlike in other nations, in Canada palliative care has its origins in university hospitals. It has subsequently developed in a few Canadian schools as an academic discipline closely linked with oncology programs. Although this model is successful, other faculties of medicine and cancer centres have been slow to emulate it. Today, the situation is rapidly changing, and both palliative care and oncology professionals are re-examining the manifest need for collaborative efforts in patient care, research and education. Palliative care must be regarded as an essential component of cancer care, its principles must be applied throughout the course of the illness and, as in other phases of cancer control, palliative care should be regarded as an exercise in prevention--prevention of suffering. This article discusses practical applications that flow from acceptance of these concepts.

References

Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A . Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer. 1988; 62(2):407-11. DOI: 10.1002/1097-0142(19880715)62:2<407::aid-cncr2820620227>3.0.co;2-t. View

Macdonald N . A march of folly. CMAJ. 1998; 158(13):1699-701. PMC: 1229440. View

Liebeskind J . Pain can kill. Pain. 1991; 44(1):3-4. DOI: 10.1016/0304-3959(91)90141-J. View

Macdonald N . Palliative care--the fourth phase of cancer prevention. Cancer Detect Prev. 1991; 15(3):253-5. View

Mayer R . Training in medical oncology: regaining the luster. J Natl Cancer Inst. 1991; 83(12):806-7. DOI: 10.1093/jnci/83.12.806. View

Portenoy R, Miransky J, Thaler H, Hornung J, Bianchi C, Feldhamer E . Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer. 1992; 70(6):1616-24. DOI: 10.1002/1097-0142(19920915)70:6<1616::aid-cncr2820700630>3.0.co;2-7. View

Coderre T, Katz J, Vaccarino A, Melzack R . Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993; 52(3):259-285. DOI: 10.1016/0304-3959(93)90161-H. View

Von Roenn J, Cleeland C, GONIN R, Hatfield A, Pandya K . Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993; 119(2):121-6. DOI: 10.7326/0003-4819-119-2-199307150-00005. View

Moore M . Dying at home: a way of maintaining control for the person with ALS/MND. Palliat Med. 1993; 7(4 Suppl):65-8. DOI: 10.1177/0269216393007004S10. View

10.

Portenoy R, Thaler H, Kornblith A, Lepore J, Coyle N, Kemeny N . Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994; 3(3):183-9. DOI: 10.1007/BF00435383. View

11.

Ham C, Hunter D, Robinson R . Evidence based policymaking. BMJ. 1995; 310(6972):71-2. PMC: 2548491. DOI: 10.1136/bmj.310.6972.71. View

12.

Ellis P, Smith I, Hardy J, Nicolson M, Talbot D, Ashley S . Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br J Cancer. 1995; 71(2):366-70. PMC: 2033578. DOI: 10.1038/bjc.1995.74. View

13.

Bruera E, Franco J, Maltoni M, Watanabe S, Suarez-Almazor M . Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage. 1995; 10(4):287-91. DOI: 10.1016/0885-3924(95)00005-J. View

14.

Vainio A . Treatment of terminal cancer pain in France: a questionnaire study. Pain. 1995; 62(2):155-162. DOI: 10.1016/0304-3959(94)00264-F. View

15.

Hope T . Evidence based medicine and ethics. J Med Ethics. 1995; 21(5):259-60. PMC: 1376770. DOI: 10.1136/jme.21.5.259. View

16.

Berenson J, Lichtenstein A, Porter L, Dimopoulos M, Bordoni R, George S . Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med. 1996; 334(8):488-93. DOI: 10.1056/NEJM199602223340802. View

17.

Bruera E . Patient assessment in palliative cancer care. Cancer Treat Rev. 1996; 22 Suppl A:3-12. DOI: 10.1016/s0305-7372(96)90058-4. View

18.

Moore M . Activity of gemcitabine in patients with advanced pancreatic carcinoma. A review. Cancer. 1996; 78(3 Suppl):633-8. DOI: 10.1002/(SICI)1097-0142(19960801)78:3<633::AID-CNCR44>3.0.CO;2-X. View

19.

Cole P, Rodu B . Declining cancer mortality in the United States. Cancer. 1996; 78(10):2045-8. DOI: 10.1002/(sici)1097-0142(19961115)78:10<2045::aid-cncr3>3.0.co;2-n. View

20.

Hortobagyi G, Theriault R, Porter L, Blayney D, Lipton A, Sinoff C . Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med. 1996; 335(24):1785-91. DOI: 10.1056/NEJM199612123352401. View